Point of Care Testing Market - Global Forecast 2025-2032

The point of care testing market is transforming how healthcare providers deliver diagnostics, driving faster, more accessible solutions conveniently integrated into patient care workflows. This report provides senior executives with the market intelligence required for guiding investment and competitive strategies.

Market Snapshot: Point of Care Testing Market Growth and Forecast

The point of care testing market is experiencing robust expansion, evidenced by recent growth from USD 32.87 billion in 2024 to USD 37.13 billion in 2025, with a projected CAGR of 13.53% through 2032. Market acceleration is supported by real-time analytics, miniaturized devices, and intuitive interface design, facilitating widespread adoption. Growing acceptance across clinical environments is also supported by smoother regulatory processes and closer integration of diagnostic tools with care delivery, enhancing both provider efficiency and patient outcomes.

Scope & Segmentation

This report offers actionable segmentation for stakeholders looking to optimize market entry, respond to evolving care models, and enhance operational performance. Businesses can align resources, product development, and partnerships through an understanding of critical market dimensions:

• Product Types: Consumables and accessories, service maintenance and calibration, software and connectivity, benchtop analyzers, molecular platforms, portable analyzers, readers and scanners, glucose test strips, hematology reagents, immunoassay reagents, lateral flow assay reagents, molecular assay kits.
• Test Types: Blood gases, cardiac markers such as B-type natriuretic peptide and troponin, comprehensive metabolic panels, drug of abuse testing, coagulation and hematology (including activated partial thromboplastin time, fibrinogen level, prothrombin time, international normalized ratio, complete blood count), infectious disease panels (gastrointestinal, respiratory, sexually transmitted), molecular diagnostics, pregnancy and fertility testing, urinalysis.
• Sample Types: Blood, nasal swab samples, saliva, urine for rapid diagnostic application and expanded patient coverage.
• Technology Platforms: Biosensor electrochemical systems, colorimetric analysis for direct observation, immunoassay systems for high-sensitivity screening, lateral flow assays (including antibody, antigen, multiplex tests), microfluidics for streamlined sample handling, PCR and molecular diagnostics for advanced pathogen detection.
• Portability: Benchtop fixed analyzers for centralized settings, portable handheld devices supporting emergency response and remote care.
• Mode of Purchase: Over-the-counter tests for consumer-driven use and prescription-based tests meeting provider and insurance requirements.
• Applications: Chronic disease management, emergency and critical care, infectious disease diagnosis, occupational health testing, oncology monitoring, women’s health solutions, all benefiting from faster access to diagnostic insight.
• End Users: Ambulatory care centers, diagnostic laboratories, free-standing emergency departments, home care providers, hospitals and clinics, urgent care centers emphasizing flexibility and responsiveness.
• Distribution Channels: Direct sales, distributor and wholesale partners for broad market reach, retail and pharmacy outlets, online channels responding to increased demand for accessibility.
• Geographical Coverage: Americas (North and Latin America), Europe, Middle East, Africa, Asia-Pacific, including established and high-growth emerging markets shaping global supply chains.
• Leading Companies: F. Hoffmann-La Roche Ltd, Abbott Laboratories, Beckman Coulter, Siemens Healthineers AG, and additional market participants driving technology and service innovation.

Key Takeaways for Senior Decision-Makers

• Decentralized and portable diagnostic solutions are enabling providers to deliver timely, actionable test results at the point of care across diverse settings.
• Integration with electronic health records streamlines workflows, promoting coordinated patient management and improved clinician productivity.
• Adoption of biosensors, advanced digital connectivity, and microfluidic technologies is expanding the range and complexity of tests possible in outpatient and remote environments.
• Patient-centered strategies, including remote monitoring and telehealth integration, are boosting demand for connected solutions tailored for chronic and preventative care workflows.
• Clarity around regulatory approvals is supporting partnership models and ensuring consistently high analytical standards, underpinning reliable global market expansion.
• Recognizing regional strengths, such as established infrastructure in North America and rapidly growing healthcare access in Asia-Pacific, is critical for responsive supply chain and investment strategy.

Tariff Impact on Supply Chains

The imposition of tariffs on diagnostic reagents and device components in 2025 is heightening complexity in global supply chains. In response, manufacturers are strengthening local supplier ties and advancing domestic production through government incentive programs. Co-investment and sourcing diversification are emerging as key tactics to mitigate risks and control costs, with special attention on adapting to market-specific regulatory and tariff developments.

Methodology & Data Sources

Market analysis is informed by comprehensive secondary research, peer-reviewed publications, and primary interviews with industry executives, clinical leaders, and regulators. Expert panel reviews and trade data assessment ensure findings are accurate, relevant, and actionable for guiding executive decisions.

Why This Report Matters

• Gain early visibility of technology innovation, regulatory trends, and competitor actions shaping the point of care testing market.
• Leverage segmented and region-specific analysis to inform leadership choices regarding investment, partnership, and product launches.
• Confidently navigate evolving patient needs, compliance requirements, and advancements in diagnostic connectivity through a forward-looking resource built for decision-makers.

Conclusion

The point of care testing market is advancing through stronger interconnectivity and agile operations. Executives who align with emerging models and partner effectively will be well positioned to realize new marketplace value.

Additional Product Information:

• Purchase of this report includes 1 year online access with quarterly updates.
• This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.